Federated Hermes’s CASI Pharmaceuticals CASI Stock Holding History

Federated Hermes’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-900,651	Closed	-$1.58M	–	2138
2022 Q4	$1.58M	Sell	900,651 -114,349	-11%	-$227K	﹤0.01%	988
2022 Q3	$2.64M	Hold	1,015,000	–	–	0.01%	840
2022 Q2	$2.9M	Hold	1,015,000	–	–	0.01%	831
2022 Q1	$8.22M	Hold	1,015,000	–	–	0.02%	657
2021 Q4	$8.12M	Hold	1,015,000	–	–	0.02%	709
2021 Q3	$12.1M	Hold	1,015,000	–	–	0.02%	600
2021 Q2	$15.7M	Hold	1,015,000	–	–	0.03%	536
2021 Q1	$24.4M	Buy	1,015,000 +315,000	+45%	+$8.85M	0.05%	440
2020 Q4	$20.6M	Buy	700,000 +10,000	+1%	+$217K	0.04%	462
2020 Q3	$10.6M	Buy	+690,000	New	+$13M	0.02%	557

Other funds holding CASI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Federated Hermes's CASI Position: Q1 2023 in Review

Federated Hermes sold out of CASI Pharmaceuticals (CASI) in Q1 2023, closing a stake of 900,651 shares — an estimated $1.58M sold.

Federated Hermes first reported a position in CASI in Q3 2020 and held it in 10 quarters. The position peaked at $24.4M in Q1 2021. 21 funds tracked by Wall St. Rank hold CASI as of Q1 2023.

Federated Hermes reported no remaining CASI Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Federated Hermes sold 900,651 CASI Pharmaceuticals shares in Q1 2023, an estimated $1.58M.
Federated Hermes first reported a position in CASI Pharmaceuticals in Q3 2020 and held it in 10 quarters.
Federated Hermes's CASI Pharmaceuticals position peaked at $24.4M in Q1 2021.
21 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2023.

Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.